Tendinopathy carries a large burden of musculoskeletal disorders seen in both athletes and aging population. Treatment is often challenging, and progression to chronic tendinopathy is common. Physical therapy, NSAIDs, and corticosteroid injections have been the mainstay of treatment but are not optimal given that most tendon disorders appear to involve degenerative changes in addition to inflammation. The field of regenerative medicine has taken the forefront, and various treatments have been developed and explored including prolotherapy, platelet rich plasma (PRP), stem cells, and percutaneous ultrasonic tenotomy. However, high-quality research with standardized protocols and consistent controls for proper evaluation of treatment efficacy is currently needed. This will make it possible to provide recommendations on appropriate treatment options for tendinopathy. Corresponding Author: Kentaro Onishi, DO, 3471 Fifth Avenue, LSK Building, Suite 201, Pittsburgh, PA 15213. Phone number: 412-246-5334. Fax number: 412-692-4410. Email: onishik2@upmc.edu Author Disclosures: This work was supported in part by the National Institutes of Health under award numbers AR065949 and AR070340 (JHW) Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
from Rehabilitation via xlomafota13 on Inoreader https://ift.tt/2qKUbdC
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.